Patent ID: 9249154
Filing Date: 2016-02-02
CPC Classification: A61K,A61P,C07D

Claim Text:
1. A method for treating a cancer that can be treated by inhibition of checkpoint protein kinase CHK1 or CHK2, wherein the cancer is selected from the group consisting of gastric cancer, colon cancer, lung cancer, ovarian cancer, and sarcoma, the method comprising administering to a patient in need thereof a pharmaceutical composition comprising a pharmaceutically acceptable excipient and a therapeutically effective amount of a compound of formula I: in the form of a racemate, a pure stereoisomer, or in the form of a mixture of stereoisomers in any mixing ratio, in the illustrated form or in the form of a salt, wherein, X=CH, N, S, O; Y=CH, S, N, O; W=CH, N, CR L=CH, N, CR R R and R